Insulin-like growth factor I is an independent coregulatory modulator of natural killer (NK) cell activity.

We aimed to investigate the natural killer (NK) cell activity in hGH-deficient adults and to analyze the effect of insulin-like growth factor (IGF)-I in vivo and in vitro on NK cell activity. NK cell activity was measured in a 4-h nonisotopic assay with europium-labeled and cryopreserved K-562 cells. NK-cell numbers were measured after incubation with murine monoclonal CD3 and CD16 antibodies by flow cytometry analysis. In a cross-sectional study, the basal and interferon-beta (IFN-beta) stimulated (1000 IU/ml) NK cell activity of 15 hGH-deficient patients and 15 age- and sex-matched controls was measured. The percentages and absolute numbers of CD3-/16+ NK-cells were not significantly different in the patient vs. control group. The basal and IFN-beta stimulated NK cell activity however was significantly decreased in the patient vs. control group at all effector/target (E/T) cell ratios from 12.5-100 (e.g. 17 +/- 3 vs. 28 +/- 3% lysis without IFN-beta, P < 0.05, and 42 +/- 4 vs. 57 +/- 4% lysis with IFN-beta, P < 0.05; both at E/T 50). IGF-I levels of patients and controls showed a significant positive correlation with NK cell activity (r = 0.37; P < 0.05). In an IGF-I in vitro study (IGF-I in vitro 250-1250 microg/L), the basal and IFN-beta stimulated NK cell activity of 13 hGH-deficient patients and of 18 normal subjects was significantly enhanced by IGF-I in vitro (e.g. GH-deficient patients: 9 +/- 2 vs. 10 +/- 2% lysis without IFN-beta, P < 0.05 and 25 +/- 4 vs. 30 +/- 4% lysis with IFN-beta, P < 0.005; and normal subjects: 15 +/- 3 vs. 23 +/- 3% lysis without IFN-beta, P < 0.001 and 35 +/- 4 vs. 44 +/- 5% lysis with IFN-beta, P < 0.001; both at IGF-I 500 microg/L). In summary, in our cross-sectional study, adult GH-deficient patients showed a significantly lower basal and IFN-beta stimulated NK cell activity than matched controls, despite equal NK cell numbers. IGF-I levels of patients and controls showed a weak positive correlation with NK cell activity. In an in vitro study, IGF-I significantly enhanced basal and IFN-beta stimulated NK cell activity of hGH-deficient patients and also of normal subjects. The decreased NK cell activity in GH-deficient patients may be caused at least in part by low serum IGF-I levels. IGF-I appears to be an independent coregulatory modulator of NK cell activity.

[1]  C. Strasburger,et al.  Effects of growth hormone and insulin-like growth factor I on the immune system. , 1995, European journal of endocrinology.

[2]  S. Lamberts,et al.  IGFBP‐3 is a poor parameter for assessment of clinical activity in acromegaly , 1995, Clinical endocrinology.

[3]  M. Cappa,et al.  Is IGF binding protein‐3 assessment helpful for the diagnosis of GH deficiency? , 1995, Clinical endocrinology.

[4]  R. Badolato,et al.  Differential expression of surface membrane growth hormone receptor on human peripheral blood lymphocytes detected by dual fluorochrome flow cytometry. , 1994, The Journal of clinical endocrinology and metabolism.

[5]  J. Frystyk,et al.  Free insulin‐like growth factors (IGF‐I and IGF‐II) in human serum , 1994, FEBS letters.

[6]  Y. Tsunematsu,et al.  Leukemia in GH Deficient Children , 1994 .

[7]  N. Igarashi,et al.  Flow Cytometric Analysis of Insulin-like Growth Factor-I (IGF-I) Receptors on Human Blood Cells , 1994 .

[8]  E. Ciccone,et al.  Human natural killer cells: origin, clonality, specificity, and receptors. , 1994, Advances in immunology.

[9]  E. Lotzová,et al.  Role of natural killer cells in cancer. , 1993, Natural immunity.

[10]  E. Hooghe-Peters,et al.  Growth hormone and prolactin are paracrine growth and differentiation factors in the haemopoietic system. , 1993, Immunology today.

[11]  Yong Ming Li,et al.  Growth hormone, prolactin, and insulin-like growth factors: New jobs for old players , 1992, Brain, Behavior, and Immunity.

[12]  C. Heijnen,et al.  Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells. , 1992, Endocrinology.

[13]  L. Lanier,et al.  Natural killer cells , 1992, Current Biology.

[14]  R. Gala.  Prolactin and Growth Hormone in the Regulation of the Immune System , 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[15]  J. Blalock,et al.  The production of growth hormone by subpopulations of rat mononuclear leukocytes. , 1991, Cellular immunology.

[16]  B. Perussia,et al.  Lymphokine-activated killer cells, natural killer cells and cytokines. , 1991, Current opinion in immunology.

[17]  D. T. Maley,et al.  Cytotoxicity assays using cryopreserved target cells pre-labeled with the fluorescent marker europium. , 1990, Journal of immunological methods.

[18]  W. Kiess,et al.  Lymphocyte subset distribution and natural killer activity in growth hormone deficiency before and during short-term treatment with growth hormone releasing hormone. , 1988, Clinical immunology and immunopathology.

[19]  J. Kraner,et al.  Exogenous growth hormone treatment alters body composition and increases natural killer cell activity in women with impaired endogenous growth hormone secretion. , 1987, Metabolism: clinical and experimental.

[20]  T. Lövgren,et al.  Europium-labelled target cells in an assay of natural killer cell activity. II. A novel non-radioactive method based on time-resolved fluorescence. significance and specificity of the method. , 1986, Journal of immunological methods.

[21]  T. Lövgren,et al.  Europium-labelled target cells in an assay of natural killer cell activity. I. A novel non-radioactive method based on time-resolved fluorescence. , 1986, Journal of immunological methods.

[22]  W. Kiess,et al.  Lymphocyte subsets and natural-killer activity in growth hormone deficiency. , 1986, The New England journal of medicine.

[23]  I. Kimber.  Natural killer cells. , 1985, Medical laboratory sciences.

[24]  R. Germain,et al.  The regulation of the immune system. , 1984, Immunology today.

[25]  A. Bøyum.  Isolation of lymphocytes, granulocytes and macrophages. , 1976, Scandinavian journal of immunology.

[26]  M GUNTHER,et al.  The ethnological and medical significance of breast feeding. , 1955, Journal of tropical pediatrics.